Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass (Q33746056)

29 July 2017

1 reference

title

Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass (English)

1 reference

acute respiratory distress syndrome

29 July 2017

1 reference

Asimakopoulos G

1

1 reference

29 July 2017

Smith PL

series ordinal

2

1 reference

29 July 2017

Ratnatunga CP

series ordinal

3

1 reference

29 July 2017

Taylor KM

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

The Annals of Thoracic Surgery

29 July 2017

1 reference

29 July 2017

68

1 reference

29 July 2017

3

1 reference

29 July 2017

1107-1115

1 reference

American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Pulmonary complications of open-heart operations: their pathogenesis and avoidance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Modifying risk for extracorporeal circulation: trial of four antiinflammatory strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Surgery with cardiopulmonary bypass and pulmonary inflammatory responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

C5A anaphylatoxin and its seven transmembrane-segment receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Requirement and role of C5a in acute lung inflammatory injury in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Markers for predicting the development of acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Complement activation and lung permeability during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Role of the contact system in fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

C5a-induced expression of P-selectin in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Adhesion molecules and inflammatory injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Tissue destruction by neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

A human urinary protease inhibitor (ulinastatin) inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass. Association with lung neutrophil sequestration and tissue peroxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Ventilation with positive end-expiratory airway pressure causes leukocyte retention in human lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

The effect of pentoxifylline on the lung during cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass. Evidence for a CD18-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Pulmonary intravascular macrophages. Role in acute lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Induction of monocyte tissue factor procoagulant activity during coronary artery bypass surgery is reduced with heparin-coated extracorporeal circuit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Tissue factor is expressed on monocytes during simulated extracorporeal circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentrations in patients undergoing cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Effect of cardiopulmonary bypass on cytokine release and adhesion molecule expression in alveolar macrophages. Preliminary report in six cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Cyclooxygenase pathway mediates lung injury induced by phorbol and platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Effects of platelet depletion on PMA-induced acute lung injury in awake sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Effect of prostacyclin PGI2 on cardiopulmonary bypass-induced lung injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Inhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Lung preservation: the importance of endothelial and alveolar type II cell integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Endogenous nitric oxide production and atrial natriuretic peptide biological activity in infants undergoing cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Adult respiratory distress syndrome: risk with common predispositions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Acute respiratory distress in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Infections and the inflammatory response in acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Sustained high levels of circulatory interleukin-8 are associated with a poor outcome in patients with adult respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Subpopulation of hyperresponsive polymorphonuclear neutrophils in patients with adult respiratory distress syndrome. Role of cytokine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Acute lung injury and the acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Surfactant medication for acute respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Clinical diagnostic criteria of the adult respiratory distress syndrome in the intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Adult respiratory distress syndrome after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Prevalence of acute respiratory distress syndrome after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

An expanded definition of the adult respiratory distress syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Heparin-coated bypass circuits reduce pulmonary injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

Inhibition of neutrophil adhesion during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2899%2900781-X

10.1016/S0003-4975(99)00781-X

7 January 2021

Identifiers

DOI

1 reference

29 July 2017

1 reference